IRIS
RECCHIUTI, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.331
AS - Asia 2.112
EU - Europa 1.977
Continente sconosciuto - Info sul continente non disponibili 394
SA - Sud America 251
AF - Africa 55
OC - Oceania 10
Totale 9.130
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.147
SG - Singapore 902
CN - Cina 502
IT - Italia 418
IE - Irlanda 250
RU - Federazione Russa 231
SE - Svezia 224
VN - Vietnam 222
BR - Brasile 187
UA - Ucraina 186
GB - Regno Unito 183
TR - Turchia 148
DE - Germania 141
IN - India 111
FR - Francia 107
CA - Canada 88
FI - Finlandia 56
AT - Austria 46
HK - Hong Kong 46
BD - Bangladesh 40
PL - Polonia 30
AR - Argentina 28
MX - Messico 27
JP - Giappone 25
NL - Olanda 21
KR - Corea 19
LT - Lituania 17
ES - Italia 16
ZA - Sudafrica 16
BE - Belgio 14
BZ - Belize 14
IL - Israele 14
EG - Egitto 13
IQ - Iraq 12
CO - Colombia 11
AU - Australia 9
IR - Iran 9
PK - Pakistan 9
GT - Guatemala 8
JM - Giamaica 8
CR - Costa Rica 7
PH - Filippine 7
AZ - Azerbaigian 6
CL - Cile 6
CZ - Repubblica Ceca 6
EC - Ecuador 6
GP - Guadalupe 6
ID - Indonesia 6
PR - Porto Rico 6
SA - Arabia Saudita 6
DZ - Algeria 5
KE - Kenya 5
PT - Portogallo 5
TT - Trinidad e Tobago 5
UZ - Uzbekistan 5
VE - Venezuela 5
BY - Bielorussia 4
EE - Estonia 4
HN - Honduras 4
MA - Marocco 4
NI - Nicaragua 4
RO - Romania 4
SV - El Salvador 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
BO - Bolivia 3
GE - Georgia 3
HR - Croazia 3
PE - Perù 3
RS - Serbia 3
SC - Seychelles 3
AL - Albania 2
CI - Costa d'Avorio 2
GR - Grecia 2
JO - Giordania 2
LB - Libano 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
PY - Paraguay 2
SN - Senegal 2
TN - Tunisia 2
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
EU - Europa 1
FJ - Figi 1
GA - Gabon 1
HU - Ungheria 1
KH - Cambogia 1
LY - Libia 1
NG - Nigeria 1
NO - Norvegia 1
OM - Oman 1
PS - Palestinian Territory 1
SI - Slovenia 1
Totale 8.738
Salva come PNG Salva come JPEG
Città #
Singapore 684
San Jose 476
Chandler 366
Ashburn 316
Dublin 248
Jacksonville 233
Council Bluffs 172
Dallas 145
Beijing 139
New York 138
Princeton 110
Dearborn 94
Santa Clara 91
Southend 88
Los Angeles 84
Izmir 77
Ann Arbor 74
Ho Chi Minh City 69
The Dalles 69
Wilmington 67
Nanjing 62
Boardman 56
Pescara 55
Buffalo 53
Hanoi 52
North Bergen 51
Chieti 47
Rome 43
Altamura 41
Houston 40
Phoenix 38
Vienna 35
Tongling 34
Montreal 33
Woodbridge 32
Hong Kong 31
Washington 31
Brooklyn 28
Cambridge 28
Hefei 26
Redondo Beach 26
Augusta 23
Munich 23
Nuremberg 23
Warsaw 23
Denver 22
San Mateo 22
Tokyo 22
Columbus 21
Moscow 21
Nanchang 21
São Paulo 21
Toronto 20
Milan 19
Helsinki 18
Dong Ket 17
Chicago 16
Naples 16
Chennai 15
Frankfurt am Main 15
Brussels 13
Johannesburg 13
League City 13
Orem 13
Seattle 13
Central 12
Falls Church 12
Mexico City 12
San Francisco 12
Ancona 11
Cairo 11
Lappeenranta 11
Shenyang 11
Tianjin 11
Agrolândia 10
Amsterdam 10
Ankara 10
Atlanta 10
Jiaxing 10
Boston 9
New Delhi 9
Seoul 9
Shanghai 9
Vilnius 9
Ascoli Piceno 8
Brasília 8
Poplar 8
Stockholm 8
Da Nang 7
Kingston 7
Kunming 7
London 7
Manchester 7
Miami 7
San José 7
Baku 6
Changsha 6
Düsseldorf 6
Haiphong 6
Hangzhou 6
Totale 5.334
Salva come PNG Salva come JPEG
Nome #
Lipoxin A4 stimulates endothelial miR-126-5p expression and its transfer via microvesicles 226
Establishment and long-term culture of human cystic fibrosis endothelial cells 218
Resolvin D1 enhances the resolution of lung inflammation caused by long-term Pseudomonas aeruginosa infection 216
Resolvin D1 improves airway inflammation and exercise capacity in cystic fibrosis lung disease. 206
Mechanisms of endothelial cell dysfunction in cystic fibrosis 199
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 189
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammation. 181
Human Periodontal Stem Cells Release Specialized Proresolving Mediators and Carry Immunomodulatory and Prohealing Properties Regulated by Lipoxins 180
MicroRNA-181b regulates ALX/FPR2 expression and proresolution signaling in human macrophages. 179
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 179
microRNA-181b is increased in cystic fibrosis cells and impairs lipoxin A4 receptor-dependent mechanisms of inflammation resolution and antimicrobial defense. 177
Lipoxins, resolvins, and the resolution of inflammation 164
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy. 163
Transcriptional regulation of the human FPR2/ALX gene: evidence of a heritable genetic variant that impairs promoter activity 163
Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis 162
Anti-inflammatory and pro-resolving properties of benzo-lipoxin A(4) analogs. 161
HARNESSING RESOLUTION MEDIATORS AS NOVEL THERAPEUTICS FOR CYSTIC FIBROSIS 157
Lipoxins and aspirin-triggered lipoxins in resolution of inflammation 157
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 156
Epigenetic regulation of the formyl peptide receptor 2 gene 156
Circulating endothelial progenitor cells and low-dose-aspirin-insensitive thromboxane biosynthesis in polycythemia rubra vera. 152
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 152
Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis 151
RESOLVIN D1 FOR TARGETING LUNG INFLAMMATION, INFECTION, AND DAMAGE IN CF 151
Resolvin D1 reduces cancer growth stimulating a protective neutrophil-dependent recruitment of anti-tumor monocytes 151
ACTIONS OF RESOLVIN D1 AND D2 IN CYSTIC FIBROSIS MRSA LUNG INFECTION AND INFLAMMATION 148
Lipoxin receptors 144
Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. 144
Resolvin D1 binds human phagocytes with evidence for proresolving receptors. 142
Homocysteine modulates the CD40/CD40L system 142
Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. 142
MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. 141
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients. 141
Resolvin D1 promotes resolution of inflammation, infection, and damage in CF 140
Novel anti-inflammatory--pro-resolving mediators and their receptors. 137
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 130
Resolvin E1 receptor activation signals phosphorylation and phagocytosis. 128
Resolvin D1 and D2 reduce SARS-CoV-2-induced inflammatory responses in cystic fibrosis macrophages 128
Reduced platelet glycoprotein Ibα shedding accelerates thrombopoiesis and COX-1 recovery: implications for aspirin dosing regimen 127
Pro-Resolving Lipid Mediators (SPMs) and Their Actions in Regulating miRNA in Novel Resolution Circuits in Inflammation. 127
Proresolving Lipid Mediators and Receptors in Stem Cell Biology: Concise Review 127
PRORESOLVING AND ANTIMICROBIAL BIOACTIONS OF MELANOCORTINS ON CF CELLS 126
Gene Expression of the D-Series Resolvin Pathway Predicts Activation of Anti-Tumor Immunity and Clinical Outcomes in Head and Neck Cancer 122
Targeting caveolin-1 deficiency in bone marrow derived cells: A new therapeutic window for fibrotic diseases? 118
Resolvin D1 and its GPCRs in resolution circuits of inflammation. 115
The Resolution Approach to Cystic Fibrosis Inflammation 115
17R-Resolvin D1 Improves Inflammatory Cardiomyopathy in a Mouse Model of Sickle Cell Disease 112
Resolution of sickle cell disease–associated inflammation and tissue damage with 17R-resolvin D1 112
RESOLVINS, LIPOXINS, AND MARESINS IN RESOLUTION OF INFLAMMATION 111
In Humanized Sickle Cell Mice, Imatinib Protects Against Sickle Cell-Related Injury 110
Impaired pro-resolving mechanisms promote abnormal NETosis, fueling autoimmunity in sickle cell disease 104
PROTECTIVE ROLE OF RVD1 AND ITS RECEPTOR IN CYSTIC FIBROSIS 103
Resolvin D1 and Resolvin D2 Protect Against Hypoxia/Reoxygenation Induced Lung and Kidney Damage in a Sickle Cell Mouse Model of Acute Vaso-Occlusive Crisis 100
Specialized pro-resolving lipid mediators and resolution of viral diseases 95
Roles of specialized pro-resolving lipid mediators in autophagy and inflammation 95
Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. 93
Targeting platelet activation with pro-resolving mediators: an innovative strategy to dampen lung inflammation in cystic fibrosis 90
Maternal, newborn and breast milk concentrations of elexacaftor/tezacaftor/ivacaftor in a F508del heterozygous woman with cystic fibrosis following successful pregnancy 90
Resolvin D1 reduces cystic fibrosis lung disease and inflammation associated with mucus obstruction 87
Immunoregulatory mechanisms of the arachidonic acid pathway in cancer 86
Mitapivat reprograms the RBC metabolome and improves anemia in a mouse model of hereditary spherocytosis 84
Resolvins Modulate Netosis and Autoimmunity in Sickle Cell Disease 81
Development and application of a liquid chromatography–mass spectrometry method for monitoring CFTR modulators in biological fluids: a step forward in personalized CF treatment 81
Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in β-thalassemic mice 80
Single cell–level pro-resolving actions of Resolvin D1 and D2 on Staphylococcus aureus lung infection and inflammation in cystic fibrosis 74
Nrf2 Plays a Key Role in Erythropoiesis during Aging 68
REPURPOSING GALLIUM FOR LOCAL TREATMENT OF BACTERIAL PNEUMONIA THROUGH INHALABLE NANO-EMBEDDED MICROPARTICLES 53
Development and application of a multimatrix LC-MS/MS method for quantifying elexacaftor-tezacaftor-ivacaftor: Expanding therapeutic drug monitoring in cystic fibrosis from systemic circulation to airways and sweat 42
17(R)-Resolvin D1 protects against sickle cell-related inflammatory cardiomyopathy in humanized mice 26
Peptide-induced lipid mediator modulation on monocyte cell line model. 12
The diadenosine tetraphosphate hydrolase ApaH contributes to Pseudomonas aeruginosa pathogenicity 7
Platelet miR-144-5p regulates COX-1/2 expression and modulates aspirin response in patients with cardiometabolic risk 4
Totale 9.130
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.346
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.346
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022239 0 0 0 0 15 11 6 22 19 15 26 125
2022/2023958 72 133 61 105 88 170 49 64 146 12 32 26
2023/2024649 54 32 37 26 35 193 97 55 7 29 19 65
2024/20251.408 74 241 147 53 85 68 90 106 122 83 155 184
2025/20262.870 254 99 236 351 309 169 548 128 309 269 145 53
2026/20271.054 45 153 237 465 154 0 0 0 0 0 0 0
Totale 9.130